MX2021001209A - Composiciones oleaginosas topicas. - Google Patents

Composiciones oleaginosas topicas.

Info

Publication number
MX2021001209A
MX2021001209A MX2021001209A MX2021001209A MX2021001209A MX 2021001209 A MX2021001209 A MX 2021001209A MX 2021001209 A MX2021001209 A MX 2021001209A MX 2021001209 A MX2021001209 A MX 2021001209A MX 2021001209 A MX2021001209 A MX 2021001209A
Authority
MX
Mexico
Prior art keywords
oleaginous compositions
topical
topical oleaginous
compositions
useful
Prior art date
Application number
MX2021001209A
Other languages
English (en)
Inventor
Sujit Kumar Dolai
Basant Amarji
Pradip Kumar Sasmal
Nv Anil Kumar Ravipati
Ujjawal Bairagi
Original Assignee
Dr Reddy´S Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Reddy´S Laboratories Ltd filed Critical Dr Reddy´S Laboratories Ltd
Publication of MX2021001209A publication Critical patent/MX2021001209A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Una composición tópica incluye una base oleaginosa y un agente activo, la cual es útil para tratar varios trastornos de la piel.
MX2021001209A 2018-08-16 2019-08-05 Composiciones oleaginosas topicas. MX2021001209A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201841009717 2018-08-16
PCT/IB2019/000737 WO2020035729A1 (en) 2018-08-16 2019-08-05 Topical oleaginous compositions

Publications (1)

Publication Number Publication Date
MX2021001209A true MX2021001209A (es) 2021-04-12

Family

ID=68296536

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021001209A MX2021001209A (es) 2018-08-16 2019-08-05 Composiciones oleaginosas topicas.

Country Status (13)

Country Link
US (1) US20200054654A1 (es)
JP (1) JP2021534161A (es)
KR (1) KR20210045987A (es)
CN (1) CN112566623A (es)
AU (1) AU2019322315A1 (es)
BR (1) BR112021002656A2 (es)
CA (1) CA3107702A1 (es)
CO (1) CO2021003103A2 (es)
EA (1) EA202190261A1 (es)
IL (1) IL280810A (es)
JO (1) JOP20210029A1 (es)
MX (1) MX2021001209A (es)
WO (1) WO2020035729A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020055773A (ja) * 2018-10-02 2020-04-09 岩城製薬株式会社 油性外用液
EP3999032A4 (en) 2019-07-16 2023-08-30 Donaghys Limited TRANSDERMAL SOLVENT SYSTEM AND METHOD OF USE
US12005038B2 (en) 2020-08-13 2024-06-11 Johnson & Johnson Consumer Inc. Methods suitable for disrupting a biofilm, and/or killing bacteria contained in a biofilm
CN114028325B (zh) * 2021-12-10 2023-08-01 福元药业有限公司 一种他克莫司软膏制剂
WO2024124467A1 (zh) * 2022-12-15 2024-06-20 科笛生物医药(无锡)有限公司 羟基二苯乙烯类化合物软膏及其用途和制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993012783A1 (en) * 1991-12-27 1993-07-08 Kureha Chemical Industry Co., Ltd. Oleaginous ointment
US6765001B2 (en) * 2001-12-21 2004-07-20 Medicis Pharmaceutical Corporation Compositions and methods for enhancing corticosteroid delivery
US20050158371A1 (en) * 2002-02-12 2005-07-21 Sumitomo Pharmaceuticals Co., Ltd. Novel external agent
EP2202229B1 (en) * 2007-08-17 2012-03-14 Eisai R&D Management Co., Ltd. Novel preparation for external use
WO2010041684A1 (ja) * 2008-10-08 2010-04-15 高田製薬株式会社 タクロリムス外用剤
GB201118193D0 (en) * 2011-10-21 2011-12-07 Jagotec Ag Improvements in or relating to oranic compounds
KR101462474B1 (ko) * 2013-10-30 2014-11-19 주식회사 큐리언트 질레우톤 크림 제형의 국소용 항염증 약학적 조성물

Also Published As

Publication number Publication date
KR20210045987A (ko) 2021-04-27
CO2021003103A2 (es) 2021-04-08
JOP20210029A1 (ar) 2021-02-14
WO2020035729A1 (en) 2020-02-20
US20200054654A1 (en) 2020-02-20
BR112021002656A2 (pt) 2021-05-11
JP2021534161A (ja) 2021-12-09
AU2019322315A1 (en) 2021-02-25
EA202190261A1 (ru) 2021-07-06
CN112566623A (zh) 2021-03-26
CA3107702A1 (en) 2020-02-20
IL280810A (en) 2021-04-29

Similar Documents

Publication Publication Date Title
MX2021001209A (es) Composiciones oleaginosas topicas.
MY196582A (en) PD-1/PD-L1 Inhibitors
MX2023004593A (es) Inhibidores de tirosina cinasa 2 (tyk2) y usos de los mismos.
GEP20227443B (en) Magl inhibitors
MX2020006128A (es) Inhibidores de la proteina de activacion de fibroblastos.
MX2023005160A (es) Compuestos de 4-aminoisoindolina-1,3-diona sustituidos y su uso para el tratamiento de linfoma.
GEP20237519B (en) Aza-heterobicyclic inhibitors of mat2a and methods of use for treating cancer
MX2022001061A (es) Agentes de interleuquina-2 y usos de los mismos.
SA519400913B1 (ar) تركيبة موضعية لتعزيز إلتئام الجروح
MX2022008479A (es) Combinaciones de brimonidina de dosis baja y usos de las mismas.
MX2021005038A (es) Dispersiones solidas y composiciones farmaceuticas que comprenden un indano sustituido y metodos para la preparacion y uso de las mismas.
MX2020012990A (es) Formulaciones de tegavivint y compuestos relacionados.
PH12021550033A1 (en) Tumor reduction formulations and methods of use thereof
ZA202207328B (en) Zeolite composition suitable for tanning leather
ZA202106519B (en) Caspase inhibitors and methods of use thereof
MX2020009813A (es) Composiciones y metodos para tratar el prurito.
WO2021041324A3 (en) Compositions and methods for the treatment of pathological pain and itch
MX2022006903A (es) Productos orales con irritacion reducida.
MX2019007041A (es) Metodos y composiciones para tratar la enfermedad de parkinson.
MX2021000314A (es) Formulaciones reductoras de tumores y metodos de uso de las mismas.
PE20200749A1 (es) Moduladores de la expresion de enac
GEP20207136B (en) Antiseptic composition comprising polyvinylpyrrolidone and unithiol and use of the composition
MX2021002444A (es) Compuestos y metodos para el tratamiento de infecciones fungicas.
MX2021005171A (es) Inhibidores de cinasas reguladas por señal extracelular (erk) y usos de los mismos.
MX2020013684A (es) Formulaciones/composiciones que comprenden ibrutinib.